BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Drug Development

  Peregrine Pharmaceuticals, Inc. Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial

  December 5, 2012

   · 

  6 min read
• National Institutes of Health (NIH) Awards Contract to Support Use of iBio, Inc.'s Proprietary Technology for Improved Anthrax Vaccine

  December 5, 2012

   · 

  4 min read
• Drug Development

  Marina Biotech, Inc. Announces That Licensee ProNAi Therapeutics, Inc. Reported Phase 1 Study Results Using SMARTICLES® Nucleic Acid Delivery Technology

  December 5, 2012

   · 

  4 min read
• Biotech Bay

  SciClone Pharmaceuticals, Inc. to Present at Oppenheimer 23rd Annual Healthcare Conference on December 13th

  December 5, 2012

   · 

  1 min read
• Drug Development

  Theravance, Inc. Announces Initiation of Phase 2 Study With TD-9855 for the Treatment of Fibromyalgia

  December 5, 2012

   · 

  6 min read
• Genetown

  PAREXEL International to Present at Oppenheimer Healthcare Conference

  December 5, 2012

   · 

  1 min read
• BioMidwest

  Uroplasty, Inc. to Participate in the Oppenheimer 23rd Annual Healthcare Conference

  December 5, 2012

   · 

  1 min read
• Pharm Country

  Optimer Pharmaceuticals, Inc. tto Present at 23rd Annual Oppenheimer Healthcare Conference

  December 5, 2012

   · 

  1 min read
• Pharm Country

  Regado Biosciences to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY

  December 5, 2012

   · 

  3 min read
• Business

  Sanguine Corporation Enters Letter of Intent

  December 5, 2012

   · 

  2 min read